PazokiR, DehghanA, EvangelouE, WarrenH, GaoH, CaulfieldM, et al..: Genetic predisposition to high blood pressure and lifestyle factors: associations with midlife blood pressure levels and cardiovascular events. Circulation137: 653–661, 2018PubMed
ArtamonovMV, SonkusareSK, GoodME, MomotaniK, EtoM, IsaksonBE, et al.. RSK2 contributes to myogenic vasoconstriction of resistance arteries by activating smooth muscle myosin and the Na(+)/H(+) exchanger [published online ahead of print Oct 30, 2018]. Sci Signal$ $doi:10.1126/scisignal.aar3924.PubMed
ArtamonovMV, SonkusareSK, GoodME, MomotaniK, EtoM, IsaksonBE, . RSK2 contributes to myogenic vasoconstriction of resistance arteries by activating smooth muscle myosin and the Na(+)/H(+) exchanger [published online ahead of print Oct 30, 2018]. Sci Signal$ $doi:10.1126/scisignal.aar3924.PubMed)| false
JohnsonAK, XueB: Central nervous system neuroplasticity and the sensitization of hypertension. Nat Rev Nephrol14: 750–766, 2018PubMed10.1038/s41581-018-0068-5)| false
GrassiG, MarkA, EslerM: The sympathetic nervous system alterations in human hypertension. Circ Res116: 976–990, 2015PubMed10.1161/CIRCRESAHA.116.303604)| false
DampneyRAL: Resetting of the baroreflex control of sympathetic vasomotor activity during natural behaviors: description and conceptual model of central mechanisms. Front Neurosci11: 461, 2017PubMed
DampneyRAL: Resetting of the baroreflex control of sympathetic vasomotor activity during natural behaviors: description and conceptual model of central mechanisms. Front Neurosci11: 461, 2017PubMed10.3389/fnins.2017.00461)| false
XueB, ZhangZ, JohnsonRF, JohnsonAK: Sensitization of slow pressor angiotensin II (Ang II)-initiated hypertension: induction of sensitization by prior Ang II treatment. Hypertension59: 459–466, 2012PubMed
XueB, ZhangZ, JohnsonRF, JohnsonAK: Sensitization of slow pressor angiotensin II (Ang II)-initiated hypertension: induction of sensitization by prior Ang II treatment. Hypertension59: 459–466, 2012PubMed10.1161/HYPERTENSIONAHA.111.185116)| false
FavaC, DorigoniS, Dalle VedoveF, DaneseE, MontagnanaM, GuidiGC, et al..: Effect of CPAP on blood pressure in patients with OSA/hypopnea a systematic review and meta-analysis. Chest145: 762–771, 2014PubMed
FavaC, DorigoniS, Dalle VedoveF, DaneseE, MontagnanaM, GuidiGC, .: Effect of CPAP on blood pressure in patients with OSA/hypopnea a systematic review and meta-analysis. Chest145: 762–771, 2014PubMed10.1378/chest.13-1115)| false
PrabhakarNR: Carotid body chemoreflex: a driver of autonomic abnormalities in sleep apnoea. Exp Physiol101: 975–985, 2016PubMed10.1113/EP085624)| false
AzizM, AmarL, LorthioirA: Resistant hypertension and obstructive sleep apnea: is there a specific indication for endovascular renal denervation?Hypertension72: 281–282, 2018
AzizM, AmarL, LorthioirA: Resistant hypertension and obstructive sleep apnea: is there a specific indication for endovascular renal denervation?Hypertension72: 281–282, 201810.1161/HYPERTENSIONAHA.118.11368)| false
WilckN, BaloghA, MarkóL, BartolomaeusH, MüllerDN: The role of sodium in modulating immune cell function. Nat Rev Nephrol15: 546–558, 2019PubMed10.1038/s41581-019-0167-y)| false
GuzikTJ, HochNE, BrownKA, McCannLA, RahmanA, DikalovS, et al..: Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med204: 2449–2460, 2007PubMed
GuzikTJ, HochNE, BrownKA, McCannLA, RahmanA, DikalovS, .: Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med204: 2449–2460, 2007PubMed10.1084/jem.20070657)| false
TrottDW, ThabetSR, KiraboA, SalehMA, ItaniH, NorlanderAE, et al..: Oligoclonal CD8+ T cells play a critical role in the development of hypertension. Hypertension64: 1108–1115, 2014PubMed
TrottDW, ThabetSR, KiraboA, SalehMA, ItaniH, NorlanderAE, .: Oligoclonal CD8+ T cells play a critical role in the development of hypertension. Hypertension64: 1108–1115, 2014PubMed10.1161/HYPERTENSIONAHA.114.04147)| false
KiraboA, FontanaV, de FariaAP, LoperenaR, GalindoCL, WuJ, et al..: DC isoketal-modified proteins activate T cells and promote hypertension. J Clin Invest124: 4642–4656, 2014PubMed
Van BeusecumJP, BarbaroNR, McDowellZ, AdenLA, XiaoL, PandeyAK, et al..: High salt activates CD11c+ antigen-presenting cells via SGK (serum glucocorticoid kinase) 1 to promote renal inflammation and salt-sensitive hypertension. Hypertension74: 555–563, 2019PubMed
KrumH, SchlaichMP, SobotkaPA, BöhmM, MahfoudF, Rocha-SinghK, et al..: Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet383: 622–629, 2014PubMed
TownsendRR, MahfoudF, KandzariDE, KarioK, PocockS, WeberMA, et al..; SPYRAL HTN-OFF MED trial investigators*: Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet390: 2160–2170, 2017PubMed
KandzariDE, BöhmM, MahfoudF, TownsendRR, WeberMA, PocockS, et al..; SPYRAL HTN-ON MED Trial Investigators: Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet391: 2346–2355, 2018PubMed
KandzariDE, BöhmM, MahfoudF, TownsendRR, WeberMA, PocockS, .; SPYRAL HTN-ON MED Trial Investigators: Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet391: 2346–2355, 2018PubMed10.1016/S0140-6736(18)30951-6)| false
FenglerK, RommelKP, BlazekS, BeslerC, HartungP, von RoederM, et al..: A three-arm randomized trial of different renal denervation devices and techniques in patients with resistant hypertension (RADIOSOUND-HTN). Circulation139: 590–600, 2019PubMed
FenglerK, RommelKP, BlazekS, BeslerC, HartungP, von RoederM, .: A three-arm randomized trial of different renal denervation devices and techniques in patients with resistant hypertension (RADIOSOUND-HTN). Circulation139: 590–600, 2019PubMed10.1161/CIRCULATIONAHA.118.037654)| false
BöhmM, KarioK, KandzariDE, MahfoudF, WeberMA, SchmiederRE, et al..; SPYRAL HTN-OFF MED Pivotal Investigators: Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED pivotal): a multicentre, randomised, sham-controlled trial [published online ahead of print Mar 27 2020]. Lancetdoi: 10.1016/S0140-6736(20)30554-7, 2020PubMed
BöhmM, KarioK, KandzariDE, MahfoudF, WeberMA, SchmiederRE, .; SPYRAL HTN-OFF MED Pivotal Investigators: Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED pivotal): a multicentre, randomised, sham-controlled trial [published online ahead of print Mar 27 2020]. Lancetdoi: 10.1016/S0140-6736(20)30554-7, 2020PubMed10.1016/S0140-6736(20)30554-7)| false
KarnikSS, UnalH, KempJR, TirupulaKC, EguchiS, VanderheydenPML, et al..: International Union of Basic and Clinical Pharmacology. XCIX. angiotensin receptors: interpreters of pathophysiological angiotensinergic stimuli [corrected]. Pharmacol Rev67: 754–819, 2015PubMed
SchüttenMT, HoubenAJ, de LeeuwPW, StehouwerCD: The link between adipose tissue renin-angiotensin-aldosterone system signaling and obesity-associated hypertension. Physiology (Bethesda)32: 197–209, 2017PubMed
SchüttenMT, HoubenAJ, de LeeuwPW, StehouwerCD: The link between adipose tissue renin-angiotensin-aldosterone system signaling and obesity-associated hypertension. Physiology (Bethesda)32: 197–209, 2017PubMed)| false
KoboriH, NangakuM, NavarLG, NishiyamaA: The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev59: 251–287, 2007PubMed
KoboriH, NangakuM, NavarLG, NishiyamaA: The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev59: 251–287, 2007PubMed10.1124/pr.59.3.3)| false
FerrarioCM, AhmadS, VaragicJ, ChengCP, GrobanL, WangH, et al..: Intracrine angiotensin II functions originate from noncanonical pathways in the human heart. Am J Physiol Heart Circ Physiol311: H404–H414, 2016PubMed
FerrarioCM, AhmadS, VaragicJ, ChengCP, GrobanL, WangH, .: Intracrine angiotensin II functions originate from noncanonical pathways in the human heart. Am J Physiol Heart Circ Physiol311: H404–H414, 2016PubMed10.1152/ajpheart.00219.2016)| false
RamkumarN, KohanDE: The (pro)renin receptor: an emerging player in hypertension and metabolic syndrome. Kidney Int95: 1041–1052, 2019PubMed10.1016/j.kint.2018.10.042)| false
YangT, XuC: Physiology and pathophysiology of the intrarenal renin-angiotensin system: an update. J Am Soc Nephrol28: 1040–1049, 2017PubMed10.1681/ASN.2016070734)| false
StankovicAR, FisherNDL, HollenbergNK: Prorenin and angiotensin-dependent renal vasoconstriction in type 1 and type 2 diabetes. J Am Soc Nephrol17: 3293–3299, 2006PubMed
StankovicAR, FisherNDL, HollenbergNK: Prorenin and angiotensin-dependent renal vasoconstriction in type 1 and type 2 diabetes. J Am Soc Nephrol17: 3293–3299, 2006PubMed10.1681/ASN.2006080859)| false
NguyenG, DelarueF, BurckléC, BouzhirL, GillerT, SraerJD: Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest109: 1417–1427, 2002PubMed
NguyenG, DelarueF, BurckléC, BouzhirL, GillerT, SraerJD: Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest109: 1417–1427, 2002PubMed10.1172/JCI0214276)| false
Riquier-BrisonADM, SiposA, PrókaiÁ, VargasSL, TomaL, MeerEJ, et al..: The macula densa prorenin receptor is essential in renin release and blood pressure control. Am J Physiol Renal Physiol315: F521–F534, 2018PubMed
SchlingP, SchäferT: Human adipose tissue cells keep tight control on the angiotensin II levels in their vicinity. J Biol Chem277: 48066–48075, 2002PubMed
SchlingP, SchäferT: Human adipose tissue cells keep tight control on the angiotensin II levels in their vicinity. J Biol Chem277: 48066–48075, 2002PubMed10.1074/jbc.M204058200)| false
LevyD, DeStefanoAL, LarsonMG, O'DonnellCJ, LiftonRP, GavrasH, et al.. Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham heart study. Hypertension36: 477–483, 2000PubMed
CooperRS, GuoX, RotimiCN, LukeA, WardR, AdeyemoA, et al..: Heritability of angiotensin-converting enzyme and angiotensinogen: a comparison of US blacks and Nigerians. Hypertension35: 1141–1147, 2000PubMed
CooperRS, GuoX, RotimiCN, LukeA, WardR, AdeyemoA, .: Heritability of angiotensin-converting enzyme and angiotensinogen: a comparison of US blacks and Nigerians. Hypertension35: 1141–1147, 2000PubMed10.1161/01.HYP.35.5.1141)| false
EhretGB, FerreiraT, ChasmanDI, Jacks103onAU, SchmidtEM, JohnsonT, et al..; CHARGE-EchoGen consortium; CHARGE-HF consortium; Wellcome Trust Case Control Consortium: The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals. Nat Genet48: 1171–1184, 2016PubMed
EhretGB, FerreiraT, ChasmanDI, Jacks103onAU, SchmidtEM, JohnsonT, .; CHARGE-EchoGen consortium; CHARGE-HF consortium; Wellcome Trust Case Control Consortium: The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals. Nat Genet48: 1171–1184, 2016PubMed10.1038/ng.3667)| false
ChoYS, GoMJ, KimYJ, HeoJY, OhJH, BanHJ, et al..: A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet41: 527–534, 2009PubMed
KatoN, TakeuchiF, TabaraY, KellyTN, GoMJ, SimX, et al..: Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat Genet43: 531–538, 2011PubMed
KatoN, TakeuchiF, TabaraY, KellyTN, GoMJ, SimX, .: Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat Genet43: 531–538, 2011PubMed10.1038/ng.834)| false
KatoN, LohM, TakeuchiF, VerweijN, WangX, ZhangW, et al..; BIOS-consortium; CARDIo GRAMplusCD; LifeLines Cohort Study; InterAct Consortium: Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation. Nat Genet47: 1282–1293, 2015PubMed
KatoN, LohM, TakeuchiF, VerweijN, WangX, ZhangW, .; BIOS-consortium; CARDIo GRAMplusCD; LifeLines Cohort Study; InterAct Consortium: Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation. Nat Genet47: 1282–1293, 2015PubMed10.1038/ng.3405)| false
WarrenHR, EvangelouE, CabreraCP, GaoH, RenM, MifsudB, et al..; International Consortium of Blood Pressure (ICBP) 1000G Analyses; BIOS Consortium; Lifelines Cohort Study; Understanding Society Scientific group; CHD Exome+ Consortium; ExomeBP Consortium; T2D-GENES Consortium; GoT2DGenes Consortium; Cohorts for Heart and Ageing Research in Genome Epidemiology (CHARGE) BP Exome Consortium; International Genomics of Blood Pressure (iGEN-BP) Consortium; UK Biobank CardioMetabolic Consortium BP working group: Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat Genet49: 403–415, 2017PubMed
WarrenHR, EvangelouE, CabreraCP, GaoH, RenM, MifsudB, .; International Consortium of Blood Pressure (ICBP) 1000G Analyses; BIOS Consortium; Lifelines Cohort Study; Understanding Society Scientific group; CHD Exome+ Consortium; ExomeBP Consortium; T2D-GENES Consortium; GoT2DGenes Consortium; Cohorts for Heart and Ageing Research in Genome Epidemiology (CHARGE) BP Exome Consortium; International Genomics of Blood Pressure (iGEN-BP) Consortium; UK Biobank CardioMetabolic Consortium BP working group: Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat Genet49: 403–415, 2017PubMed10.1038/ng.3768)| false
CicilaGT, RappJP, WangJM, St LezinE, NgSC, KurtzTW: Linkage of 11 beta-hydroxylase mutations with altered steroid biosynthesis and blood pressure in the Dahl rat. Nat Genet3: 346–353, 1993PubMed
CicilaGT, RappJP, WangJM, St LezinE, NgSC, KurtzTW: Linkage of 11 beta-hydroxylase mutations with altered steroid biosynthesis and blood pressure in the Dahl rat. Nat Genet3: 346–353, 1993PubMed10.1038/ng0493-346)| false
CrespoK, ChauvetC, BlainM, MénardA, RoyJ, DengAY: Normotension in Lewis and Dahl salt-resistant rats is governed by different genes. J Hypertens29: 460–465, 2011PubMed
CrespoK, ChauvetC, BlainM, MénardA, RoyJ, DengAY: Normotension in Lewis and Dahl salt-resistant rats is governed by different genes. J Hypertens29: 460–465, 2011PubMed10.1097/HJH.0b013e328341f1cc)| false
KiangKM, LeungGK: A review on adducin from functional to pathological mechanisms: future direction in cancer. BioMed Res Int2018: 3465929, 2018PubMed10.1155/2018/3465929)| false
CusiD, BarlassinaC, AzzaniT, CasariG, CitterioL, DevotoM, et al..: Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet349: 1353–1357, 1997PubMed
CusiD, BarlassinaC, AzzaniT, CasariG, CitterioL, DevotoM, .: Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet349: 1353–1357, 1997PubMed10.1016/S0140-6736(97)01029-5)| false
BianchiG, TripodiG, CasariG, SalardiS, BarberBR, GarciaR, et al..: Two point mutations within the adducin genes are involved in blood pressure variation. Proc Natl Acad Sci U S A91: 3999–4003, 1994PubMed
BianchiG, TripodiG, CasariG, SalardiS, BarberBR, GarciaR, .: Two point mutations within the adducin genes are involved in blood pressure variation. Proc Natl Acad Sci U S A91: 3999–4003, 1994PubMed10.1073/pnas.91.9.3999)| false
GarrisonRJ, KannelWB, StokesJ3rd, CastelliWP: Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med16: 235–251, 1987PubMed
GarrisonRJ, KannelWB, StokesJ3rd, CastelliWP: Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med16: 235–251, 1987PubMed10.1016/0091-7435(87)90087-9)| false
DingW, ChengH, ChenF, YanY, ZhangM, ZhaoX, et al..: Adipokines are associated with hypertension in metabolically healthy obese (MHO) children and adolescents: a prospective population-based cohort study. J Epidemiol28: 19–26, 2018PubMed
DingW, ChengH, ChenF, YanY, ZhangM, ZhaoX, .: Adipokines are associated with hypertension in metabolically healthy obese (MHO) children and adolescents: a prospective population-based cohort study. J Epidemiol28: 19–26, 2018PubMed10.2188/jea.JE20160141)| false
HavasS, RoccellaEJ, LenfantC: Reducing the public health burden from elevated blood pressure levels in the United States by lowering intake of dietary sodium. Am J Public Health94: 19–22, 2004PubMed
HavasS, RoccellaEJ, LenfantC: Reducing the public health burden from elevated blood pressure levels in the United States by lowering intake of dietary sodium. Am J Public Health94: 19–22, 2004PubMed10.2105/AJPH.94.1.19)| false
HeFJ, Pombo-RodriguesS, MacgregorGA: Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality. BMJ Open4: e004549–e004549, 2014PubMed
HeFJ, Pombo-RodriguesS, MacgregorGA: Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality. BMJ Open4: e004549–e004549, 2014PubMed10.1136/bmjopen-2013-004549)| false
MenteA, O’DonnellMJ, RangarajanS, McQueenMJ, PoirierP, WielgoszA, et al..; PURE Investigators: Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med371: 601–611, 2014PubMed
MenteA, O’DonnellMJ, RangarajanS, McQueenMJ, PoirierP, WielgoszA, .; PURE Investigators: Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med371: 601–611, 2014PubMed10.1056/NEJMoa1311989)| false
MozaffarianD, FahimiS, SinghGM, MichaR, KhatibzadehS, EngellRE, et al..; Global Burden of Diseases Nutrition and Chronic Diseases Expert Group: Global sodium consumption and death from cardiovascular causes. N Engl J Med371: 624–634, 2014PubMed
MozaffarianD, FahimiS, SinghGM, MichaR, KhatibzadehS, EngellRE, .; Global Burden of Diseases Nutrition and Chronic Diseases Expert Group: Global sodium consumption and death from cardiovascular causes. N Engl J Med371: 624–634, 2014PubMed10.1056/NEJMoa1304127)| false
McDonoughAA, VeirasLC, GuevaraCA, RalphDL: Cardiovascular benefits associated with higher dietary K+ vs. lower dietary Na+: evidence from population and mechanistic studies. Am J Physiol Endocrinol Metab312: E348–E356, 2017PubMed
McDonoughAA, VeirasLC, GuevaraCA, RalphDL: Cardiovascular benefits associated with higher dietary K+ vs. lower dietary Na+: evidence from population and mechanistic studies. Am J Physiol Endocrinol Metab312: E348–E356, 2017PubMed10.1152/ajpendo.00453.2016)| false
ClaseCM, CarreroJJ, EllisonDH, GramsME, HemmelgarnBR, JardineMJ, et al..; Conference Participants: Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int97: 42–61, 2020PubMed
GritterM, RotmansJI, HoornEJ: Role of dietary K+ in natriuresis, blood pressure reduction, cardiovascular protection, and renoprotection. Hypertension73: 15–23, 2019PubMed
GritterM, RotmansJI, HoornEJ: Role of dietary K+ in natriuresis, blood pressure reduction, cardiovascular protection, and renoprotection. Hypertension73: 15–23, 2019PubMed10.1161/HYPERTENSIONAHA.118.11209)| false
ArakiS, HanedaM, KoyaD, KondoK, TanakaS, ArimaH, et al..: Urinary potassium excretion and renal and cardiovascular complications in patients with type 2 diabetes and normal renal function. Clin J Am Soc Nephrol10: 2152–2158, 2015PubMed
ArakiS, HanedaM, KoyaD, KondoK, TanakaS, ArimaH, .: Urinary potassium excretion and renal and cardiovascular complications in patients with type 2 diabetes and normal renal function. Clin J Am Soc Nephrol10: 2152–2158, 2015PubMed10.2215/CJN.00980115)| false
MunKH, YuGI, ChoiBY, KimMK, ShinMH, ShinDH: Association of dietary potassium intake with the development of chronic kidney disease and renal function in patients with mildly decreased kidney function: the Korean multi-rural communities cohort study. Med Sci Monit25: 1061–1070, 2019PubMed
MunKH, YuGI, ChoiBY, KimMK, ShinMH, ShinDH: Association of dietary potassium intake with the development of chronic kidney disease and renal function in patients with mildly decreased kidney function: the Korean multi-rural communities cohort study. Med Sci Monit25: 1061–1070, 2019PubMed10.12659/MSM.913504)| false
MenteA, O’DonnellM, RangarajanS, DagenaisG, LearS, McQueenM, et al..; PURE, EPIDREAM and ONTARGET/TRANSCEND Investigators: Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet388: 465–475, 2016PubMed
MenteA, O’DonnellM, RangarajanS, DagenaisG, LearS, McQueenM, .; PURE, EPIDREAM and ONTARGET/TRANSCEND Investigators: Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet388: 465–475, 2016PubMed10.1016/S0140-6736(16)30467-6)| false
National Academies of Sciences, Engineering, and Medicine. Dietary Reference Intakes for sodium and potassium, Washington, DC, The National Academies Press, 2019
National Academies of Sciences, Engineering, and Medicine. Dietary Reference Intakes for sodium and potassium
, Washington, DC, The National Academies Press, 2019)| false
NewberrySJ, ChungM, AndersonCAM, Chen C, Fu Z, Tang A, et al..: Sodium and Potassium Intake: Effects on Chronic Disease Outcomes and Risks. In: Comparative Effectiveness Review, No. 206.Rockville, MD, Agency for Healthcare Research and Quality, 2018
NewberrySJ, ChungM, AndersonCAM, Chen C, Fu Z, Tang A, .: Sodium and Potassium Intake: Effects on Chronic Disease Outcomes and Risks. In: Comparative Effectiveness Review, No. 206.Rockville, MD, Agency for Healthcare Research and Quality, 2018)| false
Governing Board of the National Research Council: Dietary Reference Intakes: The essential guide to nutrient requirements, National Academy of Sciences, 2006
Governing Board of the National Research Council: Dietary Reference Intakes: The essential guide to nutrient requirements
, National Academy of Sciences, 2006)| false
LamelasPM, MenteA, DiazR, OrlandiniA, AvezumA, OliveiraG, et al..: Association of urinary sodium excretion with blood pressure and cardiovascular clinical events in 17,033 Latin Americans. Am J Hypertens29: 796–805, 2016PubMed
LamelasPM, MenteA, DiazR, OrlandiniA, AvezumA, OliveiraG, .: Association of urinary sodium excretion with blood pressure and cardiovascular clinical events in 17,033 Latin Americans. Am J Hypertens29: 796–805, 2016PubMed10.1093/ajh/hpv195)| false
AndersonCAM, AppelLJ, OkudaN, BrownIJ, ChanQ, ZhaoL, et al..: Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP study. J Am Diet Assoc110: 736–745, 2010PubMed
AndersonCAM, AppelLJ, OkudaN, BrownIJ, ChanQ, ZhaoL, .: Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP study. J Am Diet Assoc110: 736–745, 2010PubMed10.1016/j.jada.2010.02.007)| false
GritterM, VogtL, YeungSMH, WoudaRD, RamakersCRB, de BorstMH, et al..: Rationale and design of a randomized placebo-controlled clinical trial assessing the renoprotective effects of potassium supplementation in chronic kidney disease. Nephron140: 48–57, 2018PubMed
GritterM, VogtL, YeungSMH, WoudaRD, RamakersCRB, de BorstMH, .: Rationale and design of a randomized placebo-controlled clinical trial assessing the renoprotective effects of potassium supplementation in chronic kidney disease. Nephron140: 48–57, 2018PubMed10.1159/000490261)| false
ElliottP, DyerA, StamlerR; INTERSALT Co-operative Research Group: The INTERSALT study: results for 24 hour sodium and potassium, by age and sex. J Hum Hypertens3: 323–330, 1989PubMed
ElliottP, DyerA, StamlerR; INTERSALT Co-operative Research Group: The INTERSALT study: results for 24 hour sodium and potassium, by age and sex. J Hum Hypertens3: 323–330, 1989PubMed)| false
YangQ, LiuT, KuklinaEV, FlandersWD, HongY, GillespieC, et al..: Sodium and potassium intake and mortality among US adults: prospective data from the third national health and nutrition examination survey. Arch Intern Med171: 1183–1191, 2011PubMed
YangQ, LiuT, KuklinaEV, FlandersWD, HongY, GillespieC, .: Sodium and potassium intake and mortality among US adults: prospective data from the third national health and nutrition examination survey. Arch Intern Med171: 1183–1191, 2011PubMed10.1001/archinternmed.2011.257)| false
KienekerLM, GansevoortRT, MukamalKJ, de BoerRA, NavisG, BakkerSJL, et al.. Urinary potassium excretion and risk of developing hypertension: the prevention of renal and vascular end-stage disease study.Hypertension64: 769–776, 2014PubMed
KienekerLM, GansevoortRT, MukamalKJ, de BoerRA, NavisG, BakkerSJL, . Urinary potassium excretion and risk of developing hypertension: the prevention of renal and vascular end-stage disease study.Hypertension64: 769–776, 2014PubMed10.1161/HYPERTENSIONAHA.114.03750)| false
KimHW, ParkJT, YooTH, LeeJ, ChungW, LeeKB, et al..; KNOW-CKD Study Investigators: Urinary potassium excretion and progression of CKD. Clin J Am Soc Nephrol14: 330–340, 2019PubMed
JuraschekSP, MillerER3rd, WeaverCM, AppelLJ: Effects of sodium reduction and the DASH Diet in relation to baseline blood pressure. J Am Coll Cardiol70: 2841–2848, 2017PubMed
JuraschekSP, MillerER3rd, WeaverCM, AppelLJ: Effects of sodium reduction and the DASH Diet in relation to baseline blood pressure. J Am Coll Cardiol70: 2841–2848, 2017PubMed10.1016/j.jacc.2017.10.011)| false
TerkerAS, ZhangC, McCormickJA, LazelleRA, ZhangC, MeermeierNP, et al..: Potassium modulates electrolyte balance and blood pressure through effects on distal cell voltage and chloride. Cell Metab21: 39–50, 2015PubMed
YangL, XuS, GuoX, UchidaS, WeinsteinAM, WangT, et al..: Regulation of renal Na transporters in response to dietary K. Am J Physiol Renal Physiol315: F1032–F1041, 2018PubMed
YangL, XuS, GuoX, UchidaS, WeinsteinAM, WangT, .: Regulation of renal Na transporters in response to dietary K. Am J Physiol Renal Physiol315: F1032–F1041, 2018PubMed10.1152/ajprenal.00117.2018)| false
KruppD, EscheJ, MensinkGBM, KlenowS, ThammM, RemerT: Dietary acid load and potassium intake associate with blood pressure and hypertension prevalence in a representative sample of the German adult population. Nutrients10: 103, 2018PubMed
KruppD, EscheJ, MensinkGBM, KlenowS, ThammM, RemerT: Dietary acid load and potassium intake associate with blood pressure and hypertension prevalence in a representative sample of the German adult population. Nutrients10: 103, 2018PubMed10.3390/nu10010103)| false
Institute of Medicine: Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate, Washington, DC, National Academies Press, 2005
Institute of Medicine: Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate
, Washington, DC, National Academies Press, 2005)| false
NealB, TianM, LiN, ElliottP, YanLL, LabartheDR, et al..: Rationale, design, and baseline characteristics of the salt substitute and stroke study (SSaSS): a large-scale cluster randomized controlled trial. Am Heart J188: 109–117, 2017PubMed
NealB, TianM, LiN, ElliottP, YanLL, LabartheDR, .: Rationale, design, and baseline characteristics of the salt substitute and stroke study (SSaSS): a large-scale cluster randomized controlled trial. Am Heart J188: 109–117, 2017PubMed10.1016/j.ahj.2017.02.033)| false
DrewnowskiA, RehmCD, MaillotM, MonsivaisP: The relation of potassium and sodium intakes to diet cost among U.S. adults. J Hum Hypertens29: 14–21, 2015PubMed
DrewnowskiA, RehmCD, MaillotM, MonsivaisP: The relation of potassium and sodium intakes to diet cost among U.S. adults. J Hum Hypertens29: 14–21, 2015PubMed10.1038/jhh.2014.38)| false
Pearson-StuttardJ, BandoszP, RehmCD, PenalvoJ, WhitselL, GazianoT, et al..: Reducing US cardiovascular disease burden and disparities through national and targeted dietary policies: a modelling study. PLoS Med14: e1002311, 2017PubMed
Pearson-StuttardJ, BandoszP, RehmCD, PenalvoJ, WhitselL, GazianoT, .: Reducing US cardiovascular disease burden and disparities through national and targeted dietary policies: a modelling study. PLoS Med14: e1002311, 2017PubMed10.1371/journal.pmed.1002311)| false
GoAS, MozaffarianD, RogerVL, BenjaminEJ, BerryJD, BlahaMJ, et al..; American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation129: e28–e292, 2014PubMed
GoAS, MozaffarianD, RogerVL, BenjaminEJ, BerryJD, BlahaMJ, .; American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation129: e28–e292, 2014PubMed)| false
WheltonPK, CareyRM, AronowWS, CaseyDEJr, CollinsKJ, Dennison HimmelfarbC, et al..: 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension71: e13–e115, 2018PubMed
WheltonPK, CareyRM, AronowWS, CaseyDEJr, CollinsKJ, Dennison HimmelfarbC, .: 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension71: e13–e115, 2018PubMed)| false
Maric-BilkanC, ArnoldAP, TaylorDA, DwinellM, HowlettSE, WengerN, et al.. Report of the National Heart, Lung, and Blood Institute working group on sex differences research in cardiovascular disease: scientific questions and challenges. Hypertension67: 802–807, 2016PubMed
Maric-BilkanC, ArnoldAP, TaylorDA, DwinellM, HowlettSE, WengerN, . Report of the National Heart, Lung, and Blood Institute working group on sex differences research in cardiovascular disease: scientific questions and challenges. Hypertension67: 802–807, 2016PubMed10.1161/HYPERTENSIONAHA.115.06967)| false
MannonEC, RaySC, RyanMJ, SullivanJC: Does sex matter?: an update on the implementation of sex as a biological variable in research. Am J Physiol Renal Physiol318: F329–F331, 2020PubMed
MannonEC, RaySC, RyanMJ, SullivanJC: Does sex matter?: an update on the implementation of sex as a biological variable in research. Am J Physiol Renal Physiol318: F329–F331, 2020PubMed10.1152/ajprenal.00575.2019)| false
VeirasLC, GirardiACC, CurryJ, PeiL, RalphDL, TranA, et al..: Sexual dimorphic pattern of renal transporters and electrolyte homeostasis. J Am Soc Nephrol28: 3504–3517, 2017PubMed
HuR, McDonoughAA, LaytonAT: Functional implications of the sex differences in transporter abundance along the rat nephron: modeling and analysis. Am J Physiol Renal Physiol317: F1462–F1474, 2019PubMed
HuR, McDonoughAA, LaytonAT: Functional implications of the sex differences in transporter abundance along the rat nephron: modeling and analysis. Am J Physiol Renal Physiol317: F1462–F1474, 2019PubMed10.1152/ajprenal.00352.2019)| false
LiQ, McDonoughAA, LaytonHE, LaytonAT: Functional implications of sexual dimorphism of transporter patterns along the rat proximal tubule: modeling and analysis. Am J Physiol Renal Physiol315: F692–F700, 2018PubMed
LiQ, McDonoughAA, LaytonHE, LaytonAT: Functional implications of sexual dimorphism of transporter patterns along the rat proximal tubule: modeling and analysis. Am J Physiol Renal Physiol315: F692–F700, 2018PubMed10.1152/ajprenal.00171.2018)| false
EdwardsA, McDonoughAA: Impact of angiotensin II-mediated stimulation of sodium transporters in the nephron assessed by computational modeling. Am J Physiol Renal Physiol317: F1656–F1668, 2019PubMed
EdwardsA, McDonoughAA: Impact of angiotensin II-mediated stimulation of sodium transporters in the nephron assessed by computational modeling. Am J Physiol Renal Physiol317: F1656–F1668, 2019PubMed10.1152/ajprenal.00335.2019)| false
SabolicI, VrhovacI, ErorDB, GerasimovaM, RoseM, BreljakD, et al..: Expression of Na+-D-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences. Am J Physiol Cell Physiol302: C1174–C1188, 2012PubMed
SabolicI, VrhovacI, ErorDB, GerasimovaM, RoseM, BreljakD, .: Expression of Na+-D-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences. Am J Physiol Cell Physiol302: C1174–C1188, 2012PubMed10.1152/ajpcell.00450.2011)| false
VeirasLC, McFarlinBE, RalphDL, BunchaV, PrescottJ, ShirvaniBS, et al..: Electrolyte and transporter responses to angiotensin II induced hypertension in female and male rats and mice. Acta Physiol (Oxf)229: e13448, 2020PubMed
VeirasLC, McFarlinBE, RalphDL, BunchaV, PrescottJ, ShirvaniBS, .: Electrolyte and transporter responses to angiotensin II induced hypertension in female and male rats and mice. Acta Physiol (Oxf)229: e13448, 2020PubMed10.1111/apha.13448)| false
HeJ, GuD, ChenJ, JaquishCE, RaoDC, HixsonJE, et al..; GenSalt Collaborative Research Group: Gender difference in blood pressure responses to dietary sodium intervention in the GenSalt study. J Hypertens27: 48–54, 2009PubMed
USDA Agricultural Research Services 2019. Usual Nutrient Intake from Food and Beverages, by Gender and Age, What We Eat in America, NHANES 2013-2016. Available at: www.ars.usda.gov/nea/bhnrc/fsrg. Accessed May 6, 2020.
135.
VaidyaA, MulateroP, BaudrandR, AdlerGK: The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment. Endocr Rev39: 1057–1088, 2018PubMed
CoenG, ManniM, GiannoniMF, BianchiniG, CalabriaS, MantellaD, et al..: Ischemic nephropathy in an elderly nephrologic and hypertensive population. Am J Nephrol18: 221–227, 1998PubMed
